Director, Oncology Business Assessments

Role summary

Business Assessment (BA) is an exciting, highly collaborative, and dynamic team of professionals responsible for generating the investment cases for all pipeline and business development decisions. BA's assessments are independent by design: our credibility rests on applying the same rigor whether the analysis supports or challenges the case for investment. BA sits within Pfizer’s Global Commercial Analytics (GCA) organization under the Chief Marketing Office — a center of analytical excellence that unifies revenue forecasting across BD, in-line, and pipeline assets and elevates BA's strategic contribution across the full asset lifecycle. Our BA team is valued for proactive thought leadership, epi-forecasting expertise, innovative analytical capabilities, and ability to communicate complex and dynamic information in clear, concise, and creative ways.

The Director partners with commercial leadership, asset leads, Therapeutic Area Leadership Teams, and Worldwide Business Development to champion internal pipeline and external opportunities aligned with strategy and investment criteria. This role independently leads several concurrent commercial assessments — internal POC study-start and Phase 3 business cases, external BD cases, and early pipeline forecasts — ensuring thorough, consistent analysis to inform critical investment decisions and structure appropriate deal terms.

The Director also provides strategic input on trade-off decisions between investment options, holds forecasting and assessment approaches consistent across internal and external options, and leads the presentation of analysis and recommendations to oncology leadership. This includes leading Operating Plan submissions and keeping forecasts current for corporate-level prioritization. Given BA's flexible resourcing model across both Categories and enterprise projects, the Director may also take on other strategy projects, disease-area opportunities, potential M&A evaluations, emerging-technology platform assessments, or senior-management requests as needed.

Role responsibilities

Build and own assessments of pipeline and BD opportunities — including epidemiology-based patient flow, treatment rates, uptake and persistency curves, gross-

undefined

undefined

Gather input from key internal expert stakeholders on the potential clinical development plan or clinical profile and commercial evaluation (e.g., Global Commercial Strategy, Integrated Insights & Strategy, Medical Affairs, Global Access Strategy & Pricing, Global Marketing/Regional leaders in the US and International Commercial Organization, Research and Development, Finance)

undefined

Develop analytically supported recommendations to facilitate investment trade off decisions across Business Unit opportunities, as well as BD opportunities compared with internal pipeline investment

Determine the appropriate level of rigor and external insights/research required depending on the scenario, timeline and decision to be made

Conduct qualitative and quantitative market research with external physicians and key opinion leaders both directly and through management of consulting resources while abiding by rigorous internal customer engagement protocols

Support development of colleagues, and influence at therapeutic area or product committee level

Take and defend an independent position before oncology leadership, including recommending against an opportunity on limited information

Own Oncology’s inputs to Operating Plan and Long-Range Forecast cycles, including integration of pipeline and BD forecasts

Work flexibly and comfortably across multiple therapeutic/tumor areas; learning and work agility is a key capability

Set the team’s standard for AI-enabled assessment: evidence synthesis, competitive landscaping, model QC, and executive materials, with every assumption traceable to its source

Occasionally support additional BA and GCA projects (e.g., knowledge management, best practice synchronization, professional development) or enterprise level initiatives and evaluations using analyst reports and other secondary data

Qualifications

BA/BS required; MBA or life sciences advanced degree preferred

8+ years in the biopharmaceutical industry, life sciences consulting, financial services, or another analytical profession (7+ years with an advanced degree) — with working knowledge of healthcare and pharmaceutical trends, competitor strategy, the drug development process, and healthcare-market dynamics in the US and major ex-US markets

Demonstrated ownership of patient-based revenue forecasting and business-case work from initial build to executive-ready recommendation

Able to work with complex information — epidemiology literature, analyst reports, secondary/claims data, primary research — and distill it into an analytic framework that facilitates decision-making, including synthesizing new areas, technologies, and opportunities for executive-level briefings

Track record delivering objective investment recommendations that earn senior-leadership endorsement, balancing Category-level strategy with overall Pfizer growth strategy; strong presentation skills at the executive level

Experience coaching analytical talent, and setting methodological standards for a team

Comfortable engaging executive commercial and research leaders at all levels, at the right moments in the assessment process

Effective in a matrixed organization, leading cross-functional teams with indirect authority to deliver quick turnarounds under limited information; creative in developing new approaches to meet business goals

Business development experience across opportunity identification, commercial assessment, and high-level deal structuring

Prior experience in biopharma forecasting, life sciences consulting, or financial services

Oncology forecasting experience preferred; M&A or platform-evaluation experience; demonstrated use of AI/LLM tooling in analytical workflows

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Work Location Assignment: Hybrid

Other Job Details:

Last day to apply: November 9, 2026

The annual base salary for this position ranges from $176,600.00 to $294,300.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Candidates must be authorized to be employed in the U.S. by any employer.

U.S. work visa sponsorship (such as TN, O-1, H-1B, etc.) is not available for this role now or in the future.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information